Cytoplasmic expression of a reporter gene by co-delivery of T7 RNA polymerase and T7 promoter sequence with cationic liposomes
- 25 June 1993
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 21 (12) , 2867-2872
- https://doi.org/10.1093/nar/21.12.2867
Abstract
Expression of bacteriophage T7 RNA polymerase In mammalian cells can efficiently drive the transcription of a foreign gene controlled by the T7 promoter (Elroy-Stein et al., Proc. Natl. Acad. Scl. USA. 86, 6126–6130, 1989). We have tested the hypothesis that purified T7 RNA polymerase can be co-delivered Into mammalian cells together with a reporter gene (chloramphenlcol acetyltransferase, CAT) controlled by the T7 promoter (pT7-EMC-CAT) using DC-chol cationic liposomes. Indeed, significant level of CAT activity was observed in human lung adenocarcinoma (A549-1) cells which had been incubated with a complex of T7 RNA polymerase, pT7-EMC-CAT DNA and DC-chol cationic liposomes. The expression was specific in that T3 RNA polymerase could not replace the T7 RNA polymerase, and that co-delivered T7 RNA polymerase did not enhance the expression of a CAT gene controlled by the SV40 early promoter. The system was optimized in terms of enzyme, DNA and liposome concentrations. Time course experiment indicated that the expression of the T7 system was about 8–10 hours sooner than the SV40 system, consistent with the notion that T7 RNA polymerase does not enter into the nucleus and the transcription takes place in the cytoplasm of the transfected cells. The expression of the T7 system was transient; it declined after 30 hours post transfection, probably due to turnover of the phage enzyme in the mammalian cells. The expression system described here should be useful for gene transfer experiments which require a fast but transient expression of a foreign gene. We have also compared our delivery system with a commercial reagent, Lipofectin®, which has been used to deliver T3 or T7 RNA polymerase with a reporter plasmid encoding the T3 or T7 promoter.Keywords
This publication has 19 references indexed in Scilit:
- Immunotherapy of Malignancy by In Vivo Gene Transfer into TumorsHuman Gene Therapy, 1992
- Gene therapy for human inherited disorders: techniques and statusCritical Reviews in Oncology/Hematology, 1992
- High-efficiency protein synthesis from T7 RNA polymerase transcripts in 3T3 fibroblastsGene, 1991
- A novel cationic liposome reagent for efficient transfection of mammalian cellsBiochemical and Biophysical Research Communications, 1991
- Lipophilic polylysines mediate efficient DNA transfection in mammalian cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1991
- Creation of a T7 autogene: Cloning and expression of the gene for bacteriophage T7 RNA polymerase under control of its cognate promoterJournal of Molecular Biology, 1991
- Discrimination between bacteriophage T3 and T7 promoters by the T3 and T7 RNA polymerases depends primarily upon a three base-pair region located 10 to 12 base-pairs upstream from the start siteJournal of Molecular Biology, 1990
- Inactivation of bacteriophage T7 DNA‐dependent RNA polymerase by 5′‐p‐fluorosulfonylbenzoyladenosineEuropean Journal of Biochemistry, 1990
- Nucleotide sequence of the gene for bacteriophage T7 RNA polymeraseJournal of Molecular Biology, 1984
- Complete nucleotide sequence of bacteriophage T7 DNA and the locations of T7 genetic elementsJournal of Molecular Biology, 1983